Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-21-022947

Director bought 50,000 shares at $33.77 ($1,688,500)

From the SEC's structured data for this filing

Trades in this filing

Lamond David · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-03-24 Purchase : show line 1 in the form +50,000 $33.77 $1,688,500 1,847,109 I
Open-market purchases · 50,000 sh · avg $33.77 · $1,688,500
Loading xslF345X03/doc4.xml…